Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: A 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety - Concepedia

Concepedia

Publication | Closed Access

Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: A 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety

166

Citations

24

References

2007

Year

Nicholas J. Lowe, Dee Anna Glaser, Nina Eadie, Simon Daggett, Jonathan W. Kowalski, Pan-Yu Lai

Journal of the American Academy of Dermatology

Scleroderma52-Week Multicenter Double-blindPlacebo-controlled StudyDermatologyPrimary Axillary HyperhidrosisMedicine

References

	Year	Citations

Page 1